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Introduction: The objective of this study was to look at the 
usefulness and cost effectiveness of intraoperative frozen 
section analysis (FSA) of the ureters at the time of radical cys-
tectomy. Methods: Pathology notes of patients undergoing 
radical cystectomy for primary bladder cancer between the 
years 2000–2015 at our institution were reviewed. Results: 
A total of 196 ureteric specimens from 98 patients were re-
viewed. Of the 98 patients, 9% (n = 9) had positive ureteric 
margins, of which all were ≥ T2, with 44% (4 of 9) being T = 4. 
In all cases of positive FSA, preoperative clinical staging was 
≥ T2. In cases where cancer staging was upgraded post-cys-
tectomy, there were no cases of positive FSA. After adjusting 
for tumor stage in ≥ T2a, using Cox regression analysis, pos-
itive frozen section was associated with a 4.2 fold increase 
in overall mortality (95%CI 1.3–13.8; p = 0.02). Cost associ-
ated with FSA was AU$1,351.90 to obtain 1 positive result. 
Conclusion: Patients with positive ureteric FSA are at higher 
risk of mortality post cystectomy, despite excision to nega-
tive tissue. However, FSA of the distal ureters at cystectomy 
were unlikely to be positive unless the bladder cancer stage 
was ≥ T2. Hence, routine ureteric FSA may not be necessary 
in patients undergoing cystectomy for non-muscle invasive 
bladder tumors.
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Introduction
Bladder cancer is a commonly occurring cancer within 
the Australian population, being the fourth most common 
solid organ tumor in men, and seventh in women [1]. 
Radical cystectomy is the treatment of choice in high-
risk bladder cancer.
The European Association of Urology guidelines in 
2011 recommended the use of intraoperative frozen sec-
tion analysis (FSA) of ureters during radical cystectomy 
[2]. However, the influence of intraoperative FSA during 
radical cystectomy on intraoperative management, prog-
nosis and cost remains a topic of much debate. It adds 
both a physical burden to the patient, with longer oper-
ating time and anesthesia time, as well as economic bur-
den to the health system. Some studies suggest no overall 
clinical difference in outcome [3]. As such, the current 
EAU guidelines do not include the use of intraoperative 
FSA [4]. However, many regional centers in Australia 
continue to routinely send distal ureters for FSA at the 
time of cystectomy mainly owing to prognosis and long- 
term follow-up of regional patients, where some patients 
have limited access to healthcare. To our knowledge, 
there are no studies investigating this routine practice and 
its cost effectiveness in regional Australian centers.
As such, we aimed to investigate the usefulness and 
cost effectiveness of intraoperative FSA of the ureters at 
the time of radical cystectomy at a regional hospital in 
Australia.
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Methods
A retrospective notes review of all patients undergoing a rad-
ical cystectomy at our institution from January 2000 to August 
2015 was conducted. All patients who underwent cystectomy for 
primary bladder cancer (including transitional cell carcinoma and 
squamous cell carcinoma) were included. It was routine practice 
to send frozen sections of the distal ureters in all patients at the 
time of cystectomy. Therefore all patients had FSA. 
Patients were excluded if they had a cystectomy performed for 
non-primary bladder cancer reasons (i.e. rectal cancer invasion, 
chronic cystitis, lymphoma invasion). Data gathered included 
gender, age, preoperative biopsy stage, postoperative pathological 
stage, tumor grade, nodes, ureteric margins, soft tissue margins, 
urethral margins, length of follow-up and cancer type. Positive 
margins were defined as the presence of urothelial carcinoma, 
carcinoma in situ (CIS) or high-grade dysplasia within the initial 
frozen section specimen. If positive margins were identified more 
ureter would be resected until the margins were negative. Staging 
was based on the 2010 TNM staging system. 
Chi-squared analysis was performed to compare FSA positiv-
ity of distal ureters with gender, age, stage, tumor, grade, nodal 
status, concomitant CIS and ureteric involvement. A cox-propor-
tional hazard analysis for risk factors was performed. Finally, a 
cost-analysis was also performed based on 2015 fees. SPSS statis-
tical software (version 17.0) was used for statistical analysis.
Results
Over the years 2000–2015, a total of 116 patients un-
derwent cystectomy at our center of which 102 patients 
had a cystectomy for primary bladder cancer. Four of the 
patients had missing data and were excluded from the 
analysis, resulting in 98 patients in the final analysis. The 
total number of urologists involved were 6, with 2 primary 
pathologists reporting the results. Male to female patient 
ratio was 67:31 (2:1). Mean length of follow-up was 70 
months. Four patients had neoadjuvant chemotherapy in 
our regional center for the duration of the study. The ad-
juvant chemotherapy data was not available.
Histology of the specimens showed 92 urothelial car-
cinomas, 5 small cell carcinomas, and 1 neuroendocrine 
tumor. Histological features of the specimens including 
distribution of tumor stages are summarised in table 1. 
All patients undergoing radical cystectomy had ureters 
sent for frozen section, of which 9% (n = 9) samples were 
positive on frozen section. In all cases of positive frozen 
section ureteric margins, pathological staging was ≥ T2, 
with the greatest frequency of positive margins seen in 
T4 (n = 5), as shown in table 2. Of the 9 patients with 
positive frozen sections, 3 had CIS at the margin and the 
rest urothelial carcinoma.
Preoperative biopsy was also considered as a possible 
predictor of ureteral FSA positivity. One patient had pre-
operative clinical data missing. Distribution of preopera-
tive staging, and subsequent upstaging and downstaging 
post-cystectomy is in table 3. Of the 97 patients, 27 had 
a preoperative stage of < T2; of whom 0 subsequently 
had a positive ureteric margin on FSA. Of remainder 71 
Table 1. Histological characteristics of radical cystectomy specimens
Pathological stage
T0, Tx
CIS
Ta
T1
T2
T3
T4
Soft tissue margin 
Positive
Negative
Ureteric margin
Positive 
Negative
Urethral margin
Positive
Negative
Not reported
Lymphovascular invasion
Positive
Negative
12
  6
  1
  7
34
24
14
27
71
  9
89
19
63
16
44
54
Frequency Percent (%)
12
  6
  1
  7
33
24
14
28
72
  9
91
19
64
16
45
55
Table 2. Frozen section positivity according to pathological staging
T0, Tx
CIS
Ta
T1
T2
T3
T4
12 (12)
  6 (6)
  1 (1)
  7 (7)
34 (33)
24 (24)
14 (14)
Number (%) FS positive (%)
0 (0)
0 (0)
0 (0)
0 (0)
3 (9)
1 (4)
5 (36)
Stage
Table 3. Preoperative pathological staging, with subsequent up- and 
down-staging
CIS
Ta
T1
T2
T3
T4
12 (12)
1 (1)
13 (13)
51 (52)
15 (15)
5 (5)
Frequency (%) Up-staged (%)
1 (8)
0 (0)
3 (23)
9 (18)
5 (33)
1 (20)
Preoperative staging Down-staged (%)
4 (33)
0 (0)
5 (38)
16 (31)
0 (0)
0 (0)
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patients who had a preoperative stage of ≥ T2, 9 subse-
quently had a positive ureteric margin on FSA. Of the 9 
cases of < T2 that eventually upgraded to ≥ T2, 0 had a 
positive ureteric FSA (table 4). 
Of the 9 patients with concomitant or primary CIS, 
none had positive ureteric margin on FSA. After adjust-
ing for tumor stage in ≥ T2a, nodal positivity, metasta-
ses and positive soft tissue margins using Cox regression 
analysis, positive frozen section was associated with a 
4.2 fold increase in overall mortality (95%CI 1.3–13.8; 
p = 0.016) (table 5). Ureteric FS positivity was not in-
volved in positive lymph nodes (p > 0.05). 
Cost analysis was performed on ureteric FSA. Based 
on 2015 Medicare fees, FSA of both ureters cost AU$ 
245.80. The total amount spent on FSA for CIS/T1 blad-
der tumors was AU$ 6,390.80. Total amount spent on 
FSA for ≥ T2 bladder tumors was AU$ 17,697.60. It re-
quires 9 FSAs to detect 1 positive result, costing AU$ 
2,236.80 to detect 1 positive result. If limited to ≥ T2 
bladder tumors, it requires only 7 frozen sections to 
detect 1 positive result, and the cost decreases to AU$ 
1,351.90 to detect 1 positive result. 
Discussion
Current practice guidelines recommend the use of 
radical cystectomy with pelvic lymph node dissection 
as the treatment option for non-metastatic, muscle inva-
sive bladder cancer. EAU guidelines also recommend the 
use of FSA of the ureters at the time of surgery [2, 5]. 
However, the use of ureteric FSA at the time of surgery 
remains a point of much debate [6–9]. 
Our results find that while positive ureteric margins 
is associated with poorer overall survival; incidence of 
positive margins was fairly low (9%, n = 9), with the in-
cidence of positive ureteric margins being 0 in patients 
with a preoperative pathological stage of T < 2, even if 
they were up-staged postoperatively. Even in cases with 
concurrent CIS, ureteric margins remained negative in all 
cases. These results would suggest the selective use of 
ureteric FSA in patients with a preoperative pathological 
staging of ≥ T2a only. 
Our findings are consistent with several other studies 
conducted across the world. Several studies place the in-
cidence of positive ureteric margins on FSA at 4–15% 
[10–12]. Similarly, ureteric margin positivity has not 
been shown to be associated with lymph node positivity 
[13]. Sensitivity of intraoperative FSA has been shown to 
be quite variable 45–80%; while specificity has always 
remained high at 95–99% [10]. 
Other studies have also shown that while positive 
ureteric margins on FSA has been associated with upper 
urinary tract recurrence, it has not been associated with 
poorer disease-specific survival rates [7, 13, 14]. This is 
in contrast to our results that support the use of ureteric 
positivity as a predictor of poorer overall survival rates. 
However, it should be kept in mind that our study did not 
look at upper urinary tract recurrence and disease-spe-
cific survival. 
It’s also been suggested that upper urinary tract recur-
rence may be more prone to occur in patients with cancer 
involvement at the intramural or juxtavesical ureter [15, 
16], or in patients with CIS of the bladder [3, 17]; with 
ureteric positivity being an associated but non-indepen-
dent risk factor for recurrence. 
Practical concerns to consider include the risk of ure-
tero-enteric anastomic recurrence in patients with pos-
itive ureteric margins. Several studies have observed 
rates of anastomotic recurrence of about 0–1%, despite 
the presence of CIS or urothelial cancer in 14% of ne-
phron-ureterectomy specimens [3, 15]. While these rates 
are low, the effect of frozen section guided resection can-
not be determined. However, it should also be considered 
that even in the presence of negative margins, uretero-en-
teric recurrence can still occur.
Our cost analysis places the cost of obtaining one pos-
itive result at AU$ 2,236. Few studies have looked at the 
Table 4. Preoperative staging with ureteric margin positivity
T0/CIS/Ta/T1
≥ T2
T0/CIS/Ta/T1
Upgraded to ≥ T2
Number*
0 (0)
9 (13)
0 (0)
Preoperative staging Positive ureteric margin on FSA
26
71
9 
* One preoperative clinical data missing.
Table 5. Overall survival: multivariate analysis using cox regression anal-
ysis
T stage: > T2
Nodal positivity: ≥ 1
Metastases: ≥ 1
Positive ureteric margin
Positive soft tissue margin
Hazard ratio 
1.9–11.4
0.9–2.7
0.5–1.5
1.3–13.8
0.3–2.0
Variable 95%CI
4.6
1.5 
0.4
4.2
0.7
0.001
0.142
0.353
0.016
0.54
p
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cost associated with ureteric FSA. Our result was only 
marginally higher than Touma et al. [18], which reported 
a cost of CAN$ 2,080 (equivalent to AU$ 2,100). How-
ever, we found that diagnostic yield can potentially be 
increased by limiting the use of ureteric FSA to patients 
who are at high risk of ureteral abnormalities, such as in 
the presence of bladder CIS or in patients with a preoper-
ative staging of ≥ T2a. 
Results of this study may be limited by its retrospec-
tive nature. Surgical guidelines and practices have im-
proved and changed significantly over the past 15 years. 
Surgical practices are also likely to vary between sur-
geons, possibly affecting margin positivity [19]. In addi-
tion, this study had a relatively small number of patients, 
with even fewer numbers having concurrent or primary 
CIS. 
Conclusion
Patients with positive ureteric FSA are at higher risk 
of overall mortality post-cystectomy, despite excising the 
ureter until a negative segment is achieved. FSA of the 
distal ureters at cystectomy are however unlikely to be 
positive unless the bladder cancer stage is ≥ T2. Omitting 
routine ureteric FSA in patients undergoing cystectomy 
for non-muscle invasive bladder tumors may therefore 
provide an economic benefit without impacting on clin-
ical outcome. 
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